Status:

RECRUITING

Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding.

Lead Sponsor:

Imperial College Healthcare NHS Trust

Conditions:

Endometrial Cancer

Post-Menopausal Bleeding

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

TITLE Pipelle® under Ultrasound Guidance (PUG) to investigate post-menopausal bleeding: Randomised Controlled Trial BACKGROUND Women who are suspected of having endometrial cancer (cancer of the inne...

Detailed Description

BACKGROUND Uterine cancer is the most common gynaecological cancer in the United Kingdom with approximately 9,400 new cases diagnosed each year, over 95% arising from the endometrium. Almost all endom...

Eligibility Criteria

Inclusion

  • All patients with post-menopausal bleeding who require an endometrial biopsy.
  • Further details:
  • Post-menopausal bleeding is defined as bleeding one year after a woman's last menstrual period or bleeding six months after starting continuous combined hormone replacement therapy.
  • There is no upper age limit, however all patients must be 18 or above.
  • Strict ultrasound criteria will be followed:
  • Endometrium ≥5mm: this is the current cut off used by Imperial College Healthcare NHS Trust for a biopsy to be indicated in the context of post-menopausal bleeding.
  • Smooth, homogenous endometrium with a clearly defined border.

Exclusion

  • Focal endometrial pathology (including but not limited to endometrial polyps, type 0-2 fibroids, uterine septa and other uterine structural abnormalities).
  • Suspicion of non-benign myometrial pathology.
  • History of endometrial cancer or endometrial hyperplasia.
  • History of cervical cancer.
  • Virgo intacta.
  • Inability to tolerate vaginal examination.
  • Inability to consent.
  • The denial or withdrawal of informed written consent.

Key Trial Info

Start Date :

July 23 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 23 2027

Estimated Enrollment :

92 Patients enrolled

Trial Details

Trial ID

NCT06501846

Start Date

July 23 2024

End Date

July 23 2027

Last Update

July 15 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare Trust

London, United Kingdom, W12 0HS